期刊
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
卷 51, 期 5, 页码 817-819出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2004.06.007
关键词
-
类别
Three patients with refractory pemphigus vulgaris improved after rituximab, an anti-CD20 monoclonal antibody directed against B cells. Treatment was well tolerated immediately, but one patient developed fatal pneumocystis carinii pneumonia. Serious infections have occurred in several pemphigus patients treated with rituximab and immunosuppressive medications, warranting further evaluation of risk-benefit ratio.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据